Skip to content

Dexcom (DXCM) — insider trading

Health Care · NASDAQ

Dexcom (DXCM) has 54 reported SEC Form 4 insider transactions in our data, including 25 open-market sales among the most recent 54 (latest 2026-09-28).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-09-28 Stern Sadie Officer (EVP Chief People & Culture Off) Open-market sale 2,565 $86.15 $221.0K Form 4
2026-09-15 Brown Michael Jon Officer (EVP Chief Legal Compliance Off) Open-market sale 1,700 $84.04 $142.9K Form 4
2026-09-15 AUGUSTINOS NICHOLAS Director Open-market sale 6,539 $84.04 $549.5K Form 4
2026-09-14 AUGUSTINOS NICHOLAS Director Open-market sale 1,550 $84.02 $130.2K Form 4
2026-09-10 Sylvain Jereme M Officer (EVP, Chief Financal Officer) Open-market sale 3,638 $83.27 $302.9K Form 4
2026-09-10 Boehnlein Glenn S Director Grant / award / vesting 5,841 — $0 Form 4
2026-08-27 Stern Sadie Officer (EVP Chief People & Culture Off) Open-market sale 2,565 $88.37 $226.7K Form 4
2026-08-22 Stern Sadie Officer (EVP Chief People & Culture Off) Shares withheld for taxes / exercise cost 1,451 $92.34 $134.0K Form 4
2026-08-22 Brown Michael Jon Officer (EVP Chief Legal Compliance Off) Shares withheld for taxes / exercise cost 1,451 $92.34 $134.0K Form 4
2026-08-22 Sylvain Jereme M Officer (EVP, Chief Financal Officer) Shares withheld for taxes / exercise cost 1,451 $92.34 $134.0K Form 4
2026-08-22 Leach Jacob Steven Director, Officer (President, CEO, and Director) Shares withheld for taxes / exercise cost 1,451 $92.34 $134.0K Form 4
2026-08-20 SAYER KEVIN R Director, Officer (Executive Chair) Open-market sale 97 $91.41 $8.9K Form 4
2026-08-20 SAYER KEVIN R Director, Officer (Executive Chair) Open-market sale 7,351 $90.78 $667.3K Form 4
2026-08-20 SAYER KEVIN R Director, Officer (Executive Chair) Open-market sale 19,308 $89.71 $1.73M Form 4
2026-08-14 Brown Michael Jon Officer (EVP Chief Legal Compliance Off) Open-market sale 1,700 $91.93 $156.3K Form 4
2026-08-12 Heller Bridgette P Director Open-market sale 1,012 $88.29 $89.3K Form 4
2026-08-12 AUGUSTINOS NICHOLAS Director Bona fide gift 1,075 — $0 Form 4
2026-08-03 FOLETTA MARK G Director Open-market sale 2,000 $85.32 $170.6K Form 4
2026-07-31 FOLETTA MARK G Director Open-market sale 2,000 $80.00 $160.0K Form 4
2026-07-20 SAYER KEVIN R Director, Officer (Executive Chair) Open-market sale 26,756 $76.32 $2.04M Form 4
2026-07-15 Brown Michael Jon Officer (EVP Chief Legal Compliance Off) Open-market sale 1,700 $74.42 $126.5K Form 4
2026-07-06 SAYER KEVIN R Director, Officer (Executive Chair) Open-market sale 26,756 $72.00 $1.93M Form 4
2026-06-15 FOLETTA MARK G Director Open-market sale 199 $74.82 $14.9K Form 4
2026-06-15 FOLETTA MARK G Director Open-market sale 3,801 $74.10 $281.7K Form 4
2026-06-15 Brown Michael Jon Officer (EVP Chief Legal Compliance Off) Open-market sale 1,700 $75.55 $128.4K Form 4
2026-06-04 Coleman Jon Officer (EVP, Chief Commercial Officer) Open-market sale 4,911 $74.13 $364.1K Form 4
2026-06-03 Coleman Jon Officer (EVP, Chief Commercial Officer) Open-market sale 4,912 $73.00 $358.6K Form 4
2026-05-28 GALA RENEE D Director Grant / award / vesting 5,605 — $0 Form 4
2026-05-28 Collins Richard Alexander Director Grant / award / vesting 5,605 — $0 Form 4
2026-05-28 Ashley Euan A. Director Grant / award / vesting 5,565 — $0 Form 4
2026-05-28 Driscoll Rimma Director Grant / award / vesting 5,605 — $0 Form 4
2026-05-28 Osterloh Albert Frederick IV Director Grant / award / vesting 1,630 — $0 Form 4
2026-05-28 Heller Bridgette P Director Grant / award / vesting 5,575 — $0 Form 4
2026-05-28 FOLETTA MARK G Director Grant / award / vesting 6,331 — $0 Form 4
2026-05-28 AUGUSTINOS NICHOLAS Director Grant / award / vesting 5,575 — $0 Form 4
2026-05-28 Malady Kyle Director Grant / award / vesting 5,575 — $0 Form 4
2026-05-28 ALTMAN STEVEN R Director Grant / award / vesting 5,565 — $0 Form 4
2026-05-22 Coleman Jon Officer (EVP, Chief Commercial Officer) Shares withheld for taxes / exercise cost 7,362 $71.90 $529.3K Form 4
2026-05-22 Stern Sadie Officer (EVP Chief People & Culture Off) Shares withheld for taxes / exercise cost 1,451 $71.90 $104.3K Form 4
2026-05-22 Sylvain Jereme M Officer (EVP, Chief Financal Officer) Shares withheld for taxes / exercise cost 1,451 $71.90 $104.3K Form 4
2026-05-22 Brown Michael Jon Officer (EVP Chief Legal Compliance Off) Shares withheld for taxes / exercise cost 1,451 $71.90 $104.3K Form 4
2026-05-22 Leach Jacob Steven Director, Officer (President, CEO, and Director) Shares withheld for taxes / exercise cost 1,451 $71.90 $104.3K Form 4
2026-05-21 SAYER KEVIN R Director, Officer (Executive Chair) Open-market sale 26,759 $72.00 $1.93M Form 4
2026-05-15 Brown Michael Jon Officer (EVP, Chief Legal Officer) Open-market sale 1,700 $59.91 $101.8K Form 4
2026-05-12 Heller Bridgette P Director Open-market sale 1,012 $60.01 $60.7K Form 4
2026-05-08 ALTMAN STEVEN R Director Bona fide gift 5,037 — $0 Form 4
2026-05-08 ALTMAN STEVEN R Director Bona fide gift 5,037 — $0 Form 4
2026-05-08 FOLETTA MARK G Director Bona fide gift 5,731 — $0 Form 4
2026-05-08 FOLETTA MARK G Director Bona fide gift 5,731 — $0 Form 4
2026-05-08 Collins Richard Alexander Director Bona fide gift 5,074 — $0 Form 4
2026-05-08 Collins Richard Alexander Director Bona fide gift 5,074 — $0 Form 4
2026-05-08 AUGUSTINOS NICHOLAS Director Bona fide gift 5,046 — $0 Form 4
2026-05-08 AUGUSTINOS NICHOLAS Director Bona fide gift 5,046 — $0 Form 4
2026-04-15 Brown Michael Jon Officer (EVP, Chief Legal Officer) Open-market sale 1,700 $63.04 $107.2K Form 4

Ask the chat about DXCM's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Dexcom (DXCM).

Last updated 2026-09-28 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.